SOAT1 and primary cutaneous T-cell non-Hodgkin lymphoma: However, unlike other cutaneous T cell lymphomas, they harbour rearrangements of JAK2, predicted to induce constitutive upregulation of kinase activity, or inactivating deletions or rearrangements of SH2B3, a negative regulator of the JAK-STAT pathway.